159 related articles for article (PubMed ID: 7494317)
1. The coxsackievirus A9 RGD motif is not essential for virus viability.
Hughes PJ; Horsnell C; Hyypiä T; Stanway G
J Virol; 1995 Dec; 69(12):8035-40. PubMed ID: 7494317
[TBL] [Abstract][Full Text] [Related]
2. Efficient RGD-independent entry process of coxsackievirus A9.
Roivainen M; Piirainen L; Hovi T
Arch Virol; 1996; 141(10):1909-19. PubMed ID: 8920824
[TBL] [Abstract][Full Text] [Related]
3. RGD-dependent entry of coxsackievirus A9 into host cells and its bypass after cleavage of VP1 protein by intestinal proteases.
Roivainen M; Hyypiä T; Piirainen L; Kalkkinen N; Stanway G; Hovi T
J Virol; 1991 Sep; 65(9):4735-40. PubMed ID: 1870199
[TBL] [Abstract][Full Text] [Related]
4. The crystal structure of coxsackievirus A9: new insights into the uncoating mechanisms of enteroviruses.
Hendry E; Hatanaka H; Fry E; Smyth M; Tate J; Stanway G; Santti J; Maaronen M; Hyypiä T; Stuart D
Structure; 1999 Dec; 7(12):1527-38. PubMed ID: 10647183
[TBL] [Abstract][Full Text] [Related]
5. Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs.
Wickham TJ; Carrion ME; Kovesdi I
Gene Ther; 1995 Dec; 2(10):750-6. PubMed ID: 8750015
[TBL] [Abstract][Full Text] [Related]
6. Involvement of beta2-microglobulin and integrin alphavbeta3 molecules in the coxsackievirus A9 infectious cycle.
Triantafilou M; Triantafilou K; Wilson KM; Takada Y; Fernandez N; Stanway G
J Gen Virol; 1999 Oct; 80 ( Pt 10)():2591-2600. PubMed ID: 10573151
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to the vitronectin receptor (integrin alpha V beta 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells.
Berinstein A; Roivainen M; Hovi T; Mason PW; Baxt B
J Virol; 1995 Apr; 69(4):2664-6. PubMed ID: 7533862
[TBL] [Abstract][Full Text] [Related]
8. Entry of coxsackievirus A9 into host cells: specific interactions with alpha v beta 3 integrin, the vitronectin receptor.
Roivainen M; Piirainen L; Hovi T; Virtanen I; Riikonen T; Heino J; Hyypiä T
Virology; 1994 Sep; 203(2):357-65. PubMed ID: 7519807
[TBL] [Abstract][Full Text] [Related]
9. The nucleotide sequences of wild-type coxsackievirus A9 strains imply that an RGD motif in VP1 is functionally significant.
Chang KH; Day C; Walker J; Hyypiä T; Stanway G
J Gen Virol; 1992 Mar; 73 ( Pt 3)():621-6. PubMed ID: 1312121
[TBL] [Abstract][Full Text] [Related]
10. Induction of neutralizing antibodies by synthetic peptides representing the C terminus of coxsackievirus A9 capsid protein VP1.
Pulli T; Roivainen M; Hovi T; Hyypiä T
J Gen Virol; 1998 Sep; 79 ( Pt 9)():2249-53. PubMed ID: 9747735
[TBL] [Abstract][Full Text] [Related]
11. Site-saturation mutagenesis of the PALTAVETG motif in coxsackievirus A9 capsid protein VP1 reveals evidence of conservation of a periodic hydrophobicity profile.
Airaksinen A; Roivainen M; Stanway G; Hovi T
J Gen Virol; 1999 Aug; 80 ( Pt 8)():1919-1927. PubMed ID: 10466787
[TBL] [Abstract][Full Text] [Related]
12. Integrin alpha v beta 6 is an RGD-dependent receptor for coxsackievirus A9.
Williams CH; Kajander T; Hyypiä T; Jackson T; Sheppard D; Stanway G
J Virol; 2004 Jul; 78(13):6967-73. PubMed ID: 15194773
[TBL] [Abstract][Full Text] [Related]
13. Tropism of Coxsackie virus A9 depends on the +1 position of the RGD (arginine- glycine- aspartic acid) motif found at the C' terminus of its VP1 capsid protein.
Ioannou M; Stanway G
Virus Res; 2021 Mar; 294():198292. PubMed ID: 33388395
[TBL] [Abstract][Full Text] [Related]
14. Integrin alphaVbeta6 is a high-affinity receptor for coxsackievirus A9.
Heikkilä O; Susi P; Stanway G; Hyypiä T
J Gen Virol; 2009 Jan; 90(Pt 1):197-204. PubMed ID: 19088289
[TBL] [Abstract][Full Text] [Related]
15. Genetic analysis of a hydrophobic domain of coxsackie B3 virus protein 2B: a moderate degree of hydrophobicity is required for a cis-acting function in viral RNA synthesis.
van Kuppeveld FJ; Galama JM; Zoll J; Melchers WJ
J Virol; 1995 Dec; 69(12):7782-90. PubMed ID: 7494289
[TBL] [Abstract][Full Text] [Related]
16. Molecular epidemiology and evolution of coxsackievirus A9.
Santti J; Harvala H; Kinnunen L; Hyypiä T
J Gen Virol; 2000 May; 81(Pt 5):1361-72. PubMed ID: 10769080
[TBL] [Abstract][Full Text] [Related]
17. High affinity interactions of Coxsackievirus A9 with integrin alphavbeta3 (CD51/61) require the CYDMKTTC sequence of beta3, but do not require the RGD sequence of the CAV-9 VP1 protein.
Triantafilou M; Triantafilou K; Wilson KM; Takada Y; Fernandez N
Hum Immunol; 2000 May; 61(5):453-9. PubMed ID: 10773347
[TBL] [Abstract][Full Text] [Related]
18. Vitronectin receptors, alpha v integrins, are recognized by several non-RGD-containing echoviruses in a continuous laboratory cell line and also in primary human Langerhans' islets and endothelial cells.
Ylipaasto P; Eskelinen M; Salmela K; Hovi T; Roivainen M
J Gen Virol; 2010 Jan; 91(Pt 1):155-65. PubMed ID: 19776235
[TBL] [Abstract][Full Text] [Related]
19. Coxsackievirus A9 VP1 mutants with enhanced or hindered A particle formation and decreased infectivity.
Airaksinen A; Roivainen M; Hovi T
J Virol; 2001 Jan; 75(2):952-60. PubMed ID: 11134308
[TBL] [Abstract][Full Text] [Related]
20. Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage.
Baranowski E; Ruiz-Jarabo CM; Sevilla N; Andreu D; Beck E; Domingo E
J Virol; 2000 Feb; 74(4):1641-7. PubMed ID: 10644333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
